Adenosine modulation: A novel approach to analgesia and inflammation

Expert Opinion on Investigational Drugs

Volumn 7, Issue 4, 1998, Pages 535-543

  Kowaluk, Elizabeth a ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

5 deoxy 5 iodotubercidin; A 127157; adenosine; adenosine kinase inhibitor; adenosine receptor agonist; analgesia; GP3269; GR79236; inflammation; UP 202 32

Indexed keywords

EID: 0037678324     PISSN: 13543784     EISSN: 17447658     Source Type: Journal    
DOI: 10.1517/13543784.7.4.535     Document Type: Review

References (56)

1. WILLIAMS M, BURNSTOCK G: Purinergic neurotrans- mission and neuromodulation: a historical perspec-tive. In: Purinergic Approaches in Experimental Therapeutics. Jacobson KA, Jarvis MF (Eds.), Wiley-Liss, New York (1997): 3 – 26.
2. WILLIAMS M: Adenosine: the prototypical modulator. Neurochem. Int. (1989) 14: 249 – 264.
3. NEWBY AC: Adenosine and the concept of 'retaliatory metabolites'. Trends Biochem. ScL (1984) 2: 42 – 44.
4. PAALZOW G, PAALZOW L: The effects of caffeine and theophylline on nociceptive stimulation in the rat. Acta Pharmacol. Toxicol. (1973) 32: 22 – 32.
5. HOLMGREN M, HEDNER J, MELLSTRAND T, NORDBERG G, HEDNER TH: Characterization of the antinociceptive effects of some adenosine analogues in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. (1986) 334: 290 – 293.
6. KEIL GJ, DELANDER GE: Spinally mediated antinocicep- tion is induced in mice by an adenosine kinase, but not an adenosine deaminase inhibitor. Life ScL (1992) 51: 171 – 176.
7. AHLIJANIAN MK, TAKEMORI AE: Effects of 0-N6-(R-phenylisopropyl)adenosine and caffeine on nocicep-tion and morphine-induced analgesia, tolerance and dependence. Eur.J. Pharmacol (1985) 112: 171 – 179.
8. POON A, SAWYNOK J: Antinociception by adenosine kinase inhibitors is dependent on formalin concentra-tion. Eur. J. Pharmacol. (1995) 286: 177 – 184.
9. YAMAMOTO T, YAKSH TL: Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists. Pain (1992) 49: 121 – 128.
10. SOSNOWSKI M, YAKSH TL: Role of spinal adenosine re-ceptors in modulating the hyperesthesia produced by spinal glycine receptor antagonism. Anesth. Analg. (1989) 69: 587 – 592.
11. LEE YL, YAKSH TL: Pharmacology of the spinal adeno-sine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. J. Pharmacol. Exp. Ther. (1996) 277: 1642 – 1648.
12. KARLSTEN R, GORDH T: An At-selective adenosine ago-nist abolishes allodynia elicited by vibration and touch after intrathecal injection. Anesth. Analg. (1995) 80: 844 – 847.
13. SEGERDAHL M, EKBLOM A, SOLLEVI A: The influence of adenosine, ketamine, and morphine on experimen-tally induced ischemic pain in healthy volunteers. An-esth. Analg. (1994) 79: 787 – 791.
14. SEGERDAHL M, EKBLOM A, SJOLUND KF et al.: Systemic adenosine attenuates touch evoked allodynia induced by mustard oil in humans. NeuroReport (1995) 6: 753 – 756.
15. EKBLOM A, SEGERDAHL M, SOLLEVI A: Adenosine in-creases the cutaneous heat pain threshold in healthy volunteers. Acta Anesth. Scand. (1995) 39: 717 – 722.
16. CHOCA JI, PROUDFIT HK, GREEN RD: Identification of At and Ay adenosine receptors in the rat spinal cord. J. Pharmacol. Exp. Ther. (1987) 242: 905 – 910.
17. GEIGER JD, NAGY JI: Distribution of adenosine deami-nase activity in rat brain and spinal cord. J. Neurosci. (1986) 6: 2707 – 2714.
18. GEIGER JD, LABELLA FS, NAGY JL: Characterization and localization of adenosine receptors in rat spinal cord. Neurosci. (1984) 4: 2303 – 2310.
19. GEIGER JD, NAGY JI: Localization of 3[11]-nitrobenzy-lthioinosine binding sites in rat spinal cord and pri-mary afferent neurons. Brain Res. (1985) 347: 321 – 327.
20. SAWYNOK J, SWEENEY MI, WHITE TD: Classification of adenosine receptors mediating antinociception in the rat spinal cord. Br. J. Pharmacol (1986) 88: 923 – 930.
21. REEVE AJ, DICKENSON AH: The roles of spinal adeno-sine receptors in the control of acute and more persis-tent nociceptive responses of dorsal horn neurones in the anaesthetized rat. Br. J. Pharmacol. (1995) 116: 2221 – 2228.
22. BRUNDEGE JM, DUNWIDDIE TV: Role of adenosine as a modulator of synaptic activity in the central nervous system. Adv. Pharmacol. (1997) 39: 353 – 391.
23. SJOLUND KF, SOLLEVI A, SEGERDAHL M, LUNDEBERG T: Intrathecal adenosine analog administration reduces substance P in cerebrospinal fluid along with behav-ioural effects that suggest antinociception in rats. An-esth. Analg. (1997) 85: 627 – 632.
24. DELANDER GE, WAHL JJ: Behaviour induced by putative nociceptive neurotransmitters is inhibited by adeno-sine or adenosine analogs coadministered intrathe-rally. J. Pharmacol Exp. Ther. (1988) 246: 565 – 570.
25. LI E, PERL E: Adenosine inhibition of synaptic trans-mission in the substantia gelatinosa. J. Neurophysiol. (1994) 4: 1611 – 1621.
26. HERRICK-DAVIS K, CHIPPARI S, LUTTINGER D, WARD SJ: Evaluation of adenosine agonists as potential analge-sics. Eur. j Pharmacol. (1989) 162: 365 – 369.
27. SAWYNOK J, REID A, POON A: Peripheral antinocicep-tive effect of an adenosine kinase inhibitor, with aug-mentation by an adenosine deaminase inhibitor, in the rat formalin test. Pain (1998) 74: 75 – 81.
28. FREDHOLM BB, DUNWIDDIE TV: How does adenosineinhibit transmitter release? Trends Pharmacol. Sci. (1988) 9: 130 – 134.
29. CRONSTEIN BN, NAIME D, FIRESTEIN G: The antiinflam-matory effects of an adenosine kinase inhibitor are mediated by adenosine. Arth. Rheum. (1995) 38: 1040 – 1045.
30. FIRESTEIN GS: Anti-inflammatory effects of adenosine kinase inhibitors in acute and chronic inflammation. Drug Dev. Res. (1996) 39: 371 – 376.
31. FIRESTEIN GS, BULLOUGH DA, ERION MD et al.: Inhibi-tion of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins. j Im-munol. (1995) 154: 326 – 334.
32. PARMELY MJ, ZHOU WW, EDWARDS CK etal.: Adenosine and a related carbocyclic nucleoside analogue selec-tively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. J. Immu-nol. (1993) 151: 389 – 396.
33. SAJJADI FG, TAKABAYASHI K, FOSTER AC, DOMINGO RC, FIRESTIEN GS: Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. J. Immunol (1996) 156: 3435 – 3442.
34. FIRESTEIN GS, BOYLE D, BULLOUGH DA et al.: Protectiveeffects of an adenosine kinase inhibitor in septic shock. J. Immunol. (1994) 152: 5853 – 5859.
35. COTTAM HB, WASSON DB, SHIH HC et al.: New adeno-sine kinase inhibitors with oral anti-inflammatory ac-tivity: synthesis and biological evaluation. J. Med. Chem. (1993) 36: 3424 – 3430.
36. ROSENGREN S, BONG GW, FIRESTEIN GS: Anti-inflammatory effects of an adenosine kinase inhibitor: decreased neutrophil accumulation and vascular leak-age. J. Immunol (1995) 154: 5444 – 5451.
37. LESCH ME, FERIN MA, WRIGHT CD, SCHRIER DJ: The ef-fects of (R)-N-(1-methyl-2-phenylethyfi-adenosine PIA), a standard At-selective adenosine agonist, on rat acute models of inflammation and neutrophil func-tion. Agents Actions (1991) 34: 25 – 27.
38. SCHRIER DJ, LESCH ME, WRIGHT CD, GILBERTSON RB: The antiinflammatory effects of adenosine receptor agonists on the carrageenan-induced pleural inflam-matory response in rats. J. Immunol. (1990) 145: 1874 – 1879.
39. FIRESTEIN GS, PAINE MM, BOYLE DL: Mechanisms ofmethotrexate action in rheumatoid arthritis. Arth. Rheum. (1994) 37:193-200. © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (1998) 7(4)
40. CRONSTEIN BN, NAIME D, OSTAD E: The antiinflamma-tory mechanism of methotrexate. j Clin. Invest. (1993) 92: 2675 – 2682.
41. BONG GW, ROSENGREN S, FIRESTEIN GS: Spinal cordadenosine receptor stimulation in rats inhibits dermal neutrophil accumulation: the role of N-methyl-n-aspa-nate receptors. J. Clin. Invest. (1996) 98: 1 – 7.
42. WILLIAMS M: Progress towards purinoceptor basedtherapeutics. Curr. Opin. Invest. Drugs. (1993) 2: 1105 – 1117.
43. DAVIES LP, JAMIESON DD, BAIRD-LAMBERT JA,KAZLAUSKAS R: Halogenated pyrrolopyrimidine ana-logues of adenosine from marine organisms: pharma-cological activities and potent inhibition of adenosine kinase. Biochem. Pharmacol. (1984) 33: 347 – 355.
44. NEWBY AC, HOLMQUIST AC, ILLINGWORTH J, PEARSONJD: The control of adenosine concentration in poly-morphonuclear leukocytes, cultured cells and isolated perfused heart from the rat. Biochem. J. (1983) 214: 317 – 323.
45. PAK MA, HAAS HL, DECKING UKM, SCHRADER J: Inhibi-tion of adenosine kinase increases endogenous adeno-sine and depresses neuronal activity in hippocampal slices. Neuropharmacology (1994) 33: 1049 – 1053.
46. GOLEMBIOWSKA K, WHITE TD, SAWYNOK J: Adenosinekinase inhibitors augment release of adenosine from spinal cord slices. Eur.J. Phramacol (1996) 307: 157 – 162.
47. BRITTON DR, MIKUSA J, LEE L, WILLIAMS M, KOWALUK E:Adenosine kinase inhibition enhances kainic acid-induced increases in striatal adenosine. AbsL Soc. Neu-roscL (1996) 22: 1568.
48. BELLFRAGE M, SOLLEVI A, SEGERDAHL M etal.: Systemicadenosine infusion alleviates spontaneous and stimu-lus evoked pain in patients with peripheral neuro-pathic pain. Anesth. Analg. (1995) 81: 713 – 717.
49. SEGERDAHL M, IRESTEDT L, SOLLEVI A: Antinociceptive effect of perioperative adenosine infusion in abdomi-nal hysterectomy. A cta Anesth. Scand. (1997) 41: 180 – 185.
50. GARDNER CJ, TWISSEL DJ, COATES J, STRONG P: The ef-fects of GR79236 on plasma fatty acid concentrations, heart rate and blood pressure in the conscious rat. Eur. Pharmacol. (1994) 257: 117 – 124.
51. GUNGOR T, MALABRE P, TEULON JM et al.: N6-substituted adenosine receptor agonists. Synthesis and pharmacological activity as potent antinocicep-tive agents. J. Med. Chem. (1994) 37: 4307 – 4316.
52. ERION MD, WIESNER JB, DARE J, KOPCHO J, UGARKAR B: GP3269: an adenosine regulating agent with anticon-vulsant activity. Nucleosides Nucleotides Ther. Biol.Applic. (1996) 1 (Suppl 28).
53. BERMAN RF, CORTESE B, WIESNER JB: Anticonvulsant activity of an adenosine kinase inhibitor, GP3269, against amygdala-kindled seizures in rats. AbsL Soc. NeuroscL (1997) 23: 2162.
54. WANG B, TANG J, WHITE PF et al: The effect of GP683, an adenosine kinase inhibitor, on the desflurane anes-thetic requirement in dogs. Anesth. Analg. (1997) 85: 675 – 680.
55. KOWALUK EA, BANNON A, GUNTHER K et al: The effects of adenosine kinase (AK) inhibitors on acute thermal nociception. AbsL Soc. NeuroscL (1996) 22: 617. 6.
56. CO WART M, BENNETT MJ, GFESSER G et al: SAR of a se-ries of nucleoside analogs as adenosine kinase inhibi-tors. 213th Meeting of the American Chemical Society (1997). Elizabeth A Kowaluk